MarketInOut Stock Screener Log In | Sign Up

Astellas Pharma Inc

TSE • Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 14:35
Astellas Pharma Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSE
Market Capitalization4,029,798 mln
Float1,713 mln
Earnings Date10/29/2026

EPS

203
Exceptional

P / E

12.37
Fair value

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.5
Borderline

1-Year Forecast

2,529.29
Fairly priced

Relative Strength

98 / 100
Top performer

Business Description

Astellas Pharma is a Japanese pharmaceutical company founded in 1923 that develops and sells medicines across several health areas, including cancer, kidney disease, eye conditions, and women's health. Its product lineup includes treatments for prostate cancer, leukemia, bladder problems, and menopause symptoms, among others. The company also pursues partnerships to expand its reach, such as collaborations focused on RNA-based therapies and diabetes care solutions.

Key Fundamentals

EPS203
P/E12.37
ROE21.20
RPS1,270
ROIC12.36
ROA10.36
Interest Cover43.91
EBITDA, mln681,690
EV / EBITDA6.55
EV / EBIT9.21
Revenue, mln2,274,365
EV / Revenue1.96

Quote Details

Last 2,510.50
Change -7.5 (-0.3%)
Open 2,513.00
Volume 2,738,200
Turnover 6,874,251,264
Average Volume 5,442,200

Financial Ratios

Pre-Tax Profit Margin21
Leverage Ratio1.90
Current Ratio1.20
Price / Book2.14
Price / Tangible Book8.83
Price / Cash Flow6.73
Price / Free Cash Flow7.72
Debt / Equity0.30
Price / Sales1.83
PEG Ratio0.75

Financial Strength

Altman Z-Score2.91
Piotroski F-Score 7 / 9
Beneish M-Score-2.5
Price to Intrinsic Value0.84
Price to Lynch Fair Value0.67
Price to Graham Number2.12
1-Year Target Price2,529.29
Shiller PE Ratio25.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.8% 79 / 100   
1 Month 8.49% 94 / 100   
2 Months 18.89% 90 / 100   
6 Months 1.14% 55 / 100   
1 Year 63.46% 90 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog